Brief: Nanthealth Announces FDA Marketing Authorization Of Omics Core
12/11/2019 14:28
Nov 12 (Reuters) - NantHealth Inc NH.O :
* NANTHEALTH ANNOUNCES FDA MARKETING AUTHORIZATION OF OMICS
CORE
Source text for Eikon: ID:nBw9zrXKfa
Further company coverage: NH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanthealth
See all newsNantHealth plunges on Nasdaq share suspension notice
Brief: Nanthealth Inc On May 22 Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On May 24
Brief: NantHealth Announces 1-For-15 Reverse Stock Split
NantHealth Inc reports results for the quarter ended in March - Earnings Summary
Brief: NantHealth Reports 2022 First Quarter Financial Results